SuperworthEnovis CORP profit margin ENOV
Gross, operating and net profit as a share of revenue over the last twelve months, from 2010.
- Net margin, 12 months
- −48.0%
- Operating margin, 12 months
- −45.1%
- Net margin on a year earlier
- −10.2 pts
- Peer median
- 7.7%
Over the twelve months to Jul 3, 2026, Enovis CORP kept −48.0% of its revenue as net profit, with an operating margin of −45.1% and a gross margin of 61.1%.
Five years earlier its net margin was 4.1%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.7%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −52.7% | −50.0% | 59.8% |
| FY2024 | −39.2% | −36.8% | 56.0% |
| FY2023 | −1.9% | −3.8% | 58.0% |
| FY2022 | −0.9% | −4.6% | 55.6% |
| FY2021 | 5.0% | 6.3% | 54.5% |
| FY2020 | 1.4% | 5.3% | 41.9% |
| FY2019 | −15.9% | 6.1% | 42.1% |
| FY2018 | 6.4% | 8.7% | 33.3% |
| FY2017 | 4.6% | 0.9% | 31.2% |
| FY2016 | 4.0% | 7.7% | 31.2% |
| FY2015 | 4.2% | 7.2% | 31.6% |
| FY2014 | 8.5% | 8.9% | 32.0% |
| FY2013 | 4.2% | 9.7% | 31.0% |
| FY2012 | −1.6% | 3.6% | 29.4% |
| FY2011 | 0.7% | 3.7% | 34.6% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −48.0% | −10.2 pts | −45.1% | |
| Q1 FY26 | −49.9% | −12.3 pts | −47.0% | |
| Q4 FY25 | −52.7% | −13.5 pts | −50.0% | |
| Q3 FY25 | −61.2% | −55.3 pts | −57.6% | |
| Q2 FY25 | −37.8% | −33.1 pts | −34.7% | |
| Q1 FY25 | −37.6% | −33.1 pts | −36.6% | |
| Q4 FY24 | −39.2% | −37.2 pts | −36.8% | |
| Q3 FY24 | −6.0% | −1.4 pts | −5.8% | |
| Q2 FY24 | −4.7% | +3.8 pts | −5.5% | |
| Q1 FY24 | −4.5% | −1.3 pts | −4.2% | |
| Q4 FY23 | −1.9% | −1.1 pts | −3.8% | |
| Q3 FY23 | −4.5% | −6.0 pts | −5.3% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Enovis CORP's size, closest first, today.
| Company | Profit margin |
|---|---|
| ENOVEnovis CORP | −48.0% |
| BVSBioventus | 9.4% |
| CDRECadre | 5.3% |
| STAAStaar Surgical | 1.1% |
| IRMDIradimed | 26.7% |
| EYENational Vision | 2.5% |
| LMATLemaitre Vascular | 25.0% |
| INSPInspire Medical Systems | 15.0% |
| MOVMovado | 6.0% |
| UFPTUFP Technologies | 11.4% |
| MDXGMimedx | 1.8% |
| Peer median | 7.7% |
Where Enovis CORP ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Enovis CORP
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.